StockData

Ingersoll Rand vs Zurn Elkay Water Solutions

IR and ZWS side by side, both in general industrial machinery and equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How IR and ZWS compare

Ingersoll Rand is the larger company, worth 4.2 times as much as Zurn Elkay Water Solutions ($31.5B against $7.5B).

On earnings, Ingersoll Rand is cheaper: it trades at 23.1× trailing earnings, against 26.3× for Zurn Elkay Water Solutions.

Zurn Elkay Water Solutions grew revenue faster over the last twelve months (10.1% versus 8.0% for Ingersoll Rand).

Ingersoll Rand keeps more of each dollar of sales as profit, with a net margin of 17.2% compared with 15.9% at Zurn Elkay Water Solutions.

Both pay dividends: Ingersoll Rand yields 0.07% and Zurn Elkay Water Solutions 0.97%.

Zurn Elkay Water Solutions scores higher on the StockData Score (21 against 17 for Ingersoll Rand), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricIRZWS
Size and price
Market cap$31.5B$7.5B
Share price$82.07$45.28
Change, 1 year8.7%−1.7%
Change, 5 years39.2%25.5%
Beta (5Y)0.540.58
Employees21K2,600
StockData Score
Total score1721 (better)
Valuation score5 (better)4
Growth score13 (better)
Performance score45 (better)
Health score46 (better)
Dividend score33
Valuation
P/E23.1× (better)26.3×
P/S3.9× (better)4.1×
P/B3.0× (better)4.4×
EV/EBITDA14.6× (better)19.0×
P/FCF20.8×–
PEG–0.62
FCF yield4.8%–
Fair value$112.53$49.67
Margin of safety27.1% (better)8.8%
Growth
Revenue growth (TTM)8.0%10.1% (better)
Revenue growth, 5Y average14.0% (better)−3.7%
Net income growth (TTM)154% (better)51.1%
EPS growth (TTM)163% (better)53.6%
EPS growth, 5Y average–32.7%
Profitability
Gross margin43.1%50.4% (better)
Operating margin22.9% (better)22.1%
Net margin17.2% (better)15.9%
FCF margin18.8%–
Return on equity13.4%17.7% (better)
Return on invested capital11.5%16.4% (better)
Financial health
Debt / equity0.450.30 (better)
Net debt / EBITDA1.420.48 (better)
Interest coverage7.2×16.1× (better)
Current ratio1.692.85 (better)
Altman Z-score3.554.89 (better)
Piotroski F-score58 (better)
Dividends and buybacks
Dividend yield0.07%0.97% (better)
Payout ratio2.2%25.3%
Years of dividend growth–4
Buyback yield3.2% (better)2.1%
Shareholder yield3.3% (better)3.1%
Ownership
Held by institutions105%89.8%
Held by insiders0.21%2.7%
Insider net buying, 12 months−$59.4M−$36.8M (better)
Superinvestors holding1–
Short interest, % of float3.8%2.3%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.